V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001774 | 230008096 | null | null | null | null | 2020-01-12 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101164593 |
| 230001775 | 230008097 | 1.5 | 61 | null | null | 2019-08-24 | ICON8 TRIAL | 02 | null | ICON8B TRIAL | 100888768 |
| 230001781 | 230008101 | 1.6 | 70 | null | 2018-11-18 | 2019-01-13 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101484582 |
| 230001786 | 230008102 | null | null | Palliative (P) | 2017-06-01 | 2017-06-03 | Rucaparib | 02 | N | RUCAPARIB | 101843485 |
| 230001791 | 230008105 | 1.35 | 56.3 | Palliative (P) | null | 2021-03-20 | null | null | N | PACLITAXEL | 101315938 |
| 230001793 | 230008106 | 1.62 | 42 | null | 2018-03-09 | 2018-09-18 | PACLITAXEL | 02 | null | PACLITAXEL | 101607821 |
| 230001797 | 230008108 | 1.71 | 138.6 | null | null | 2019-05-28 | Bevacizumab+Carbo+Pacliaxel | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100611585 |
| 230001798 | 230008109 | 1.68 | 58.8 | null | 2019-07-09 | 2019-07-27 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101110498 |
| 230001803 | 230008112 | null | 0 | Adjuvant (A) | 2018-03-27 | 2018-11-12 | CISPLATIN + ETOPOSIDE | 02 | N | NIVOLUMAB | 101136294 |
| 230001809 | 230008115 | 1.63 | 67.7 | Adjuvant (A) | 2019-08-20 | 2020-06-14 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100132664 |
| 230001810 | 230008116 | 1.53 | 92 | Palliative (P) | null | 2018-08-04 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101108378 |
| 230001812 | 230008117 | 1.52 | 87.05 | Palliative (P) | 2019-12-08 | 2020-01-25 | Bevacizumab | 02 | N | BEVACIZUMAB | 101686049 |
| 230001815 | 230008118 | 1.53 | 66.6 | null | 2020-10-24 | 2020-10-30 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101779065 |
| 230001817 | 230008119 | 1.63 | 53.8 | Palliative (P) | null | 2019-05-03 | Olaparib | 02 | N | OLAPARIB | 100834006 |
| 230001819 | 230008121 | null | null | null | 2018-07-11 | 2018-09-06 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101032091 |
| 230001822 | 230008123 | 1.5 | 56.3 | Neo-adjuvant (N) | 2019-05-30 | 2019-06-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101218559 |
| 230001828 | 230008125 | 1.7 | 75 | null | null | 2021-01-07 | null | N | null | PACLITAXEL | 100446663 |
| 230001829 | 230008126 | 1.52 | 56 | null | null | 2020-03-19 | null | null | null | BEVACIZUMAB | 100408458 |
| 230001835 | 230008128 | 1.51 | 105.3 | null | 2020-08-09 | 2020-08-09 | TOPOTECAN | 02 | null | TRIAL UNSPECIFIED | 101058651 |
| 230001840 | 230008131 | 1.58 | 83 | null | null | 2021-01-23 | null | null | null | BEVACIZUMAB | 100630875 |
| 230001841 | 230008132 | 1.57 | 77.2 | null | null | 2017-07-03 | null | null | null | BEVACIZUMAB | 101359449 |
| 230001844 | 230008133 | null | null | null | 2020-04-03 | 2020-07-05 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101500385 |
| 230001846 | 230008134 | null | null | null | 2020-09-01 | 2020-09-06 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100249299 |
| 230001848 | 230008135 | null | null | null | 2021-07-28 | 2021-08-26 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101558616 |
| 230001850 | 230008137 | 1.6 | 70.6 | Neo-adjuvant (N) | 2015-12-16 | 2018-04-18 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100891161 |
| 230001851 | 230008138 | 1.52 | 81.4 | Palliative (P) | 2022-04-15 | 2022-05-07 | Bevacizumab | 02 | N | BEVACIZUMAB | 101144977 |
| 230001854 | 230008139 | 1.59 | 66.4 | null | null | 2020-04-02 | Olaparib | 02 | null | OLAPARIB | 101816803 |
| 230001857 | 230008140 | 1.59 | 53.4 | null | 2020-09-25 | 2020-12-25 | Niraparib | 02 | null | NIRAPARIB | 100311486 |
| 230001865 | 230008143 | null | null | Adjuvant (A) | null | 2017-11-20 | GEMCITABINE | null | null | NIRAPARIB | 101083578 |
| 230001870 | 230008146 | 1.59 | 63.7 | null | 2022-04-10 | 2022-04-11 | null | null | null | PACLITAXEL | 101857326 |
| 230001873 | 230008147 | null | null | Curative (C) | null | 2021-04-03 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101552669 |
| 230001874 | 230008148 | null | null | null | 2019-10-24 | 2022-03-07 | Olaparib | 02 | null | OLAPARIB | 101123322 |
| 230001876 | 230008150 | 1.57 | 52.7 | null | 2020-06-16 | 2020-07-13 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101241810 |
| 230001879 | 230008151 | 1.67 | 76.1 | Adjuvant (A) | 2021-12-22 | 2022-03-16 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101577356 |
| 230001882 | 230008153 | 1.61 | 60 | Adjuvant (A) | 2019-07-25 | 2019-07-25 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101329981 |
| 230001886 | 230008154 | 1.59 | 97.6 | null | null | 2017-09-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100798503 |
| 230001890 | 230008156 | 1.56 | 55.7 | null | 2019-06-02 | 2019-06-03 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 101429851 |
| 230001892 | 230008157 | 1.7 | 42 | null | 2019-11-15 | 2022-03-02 | null | 02 | null | TRIAL UNSPECIFIED | 100977905 |
| 230001895 | 230008158 | 1.75 | 74.2 | Palliative (P) | 2020-01-08 | 2020-01-12 | CARBOPLATIN | 02 | N | CARBOPLATIN | 100799567 |
| 230001898 | 230008160 | 1.52 | 139.5 | Adjuvant (A) | 2016-03-29 | 2016-03-30 | Niraparib | 02 | N | NIRAPARIB | 101715764 |
| 230001901 | 230008161 | 1.55 | 101 | Palliative (P) | null | 2022-01-06 | null | null | N | CISPLATIN | 101360949 |
| 230001903 | 230008162 | null | null | null | 2017-06-15 | 2020-09-14 | null | null | null | PACLITAXEL | 100289576 |
| 230001904 | 230008163 | 1.67 | 56 | null | 2021-02-19 | 2021-02-19 | PACLITAXEL | 02 | null | PACLITAXEL | 100900357 |
| 230001909 | 230008165 | 1.57 | 47.3 | null | 2020-11-19 | 2020-12-03 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 100692521 |
| 230001911 | 230008166 | 1.71 | 51.2 | null | null | 2018-12-17 | Bevacizumab 7.5mg/kg | 01 | null | LIPOSOMAL DOXORUBICIN | 100037088 |
| 230001912 | 230008167 | null | null | Neo-adjuvant (N) | null | 2019-06-02 | PEMBROLIZUMAB | 02 | N | CISPLATIN | 100304164 |
| 230001917 | 230008171 | 1.57 | 58 | null | null | 2016-11-24 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101627896 |
| 230001919 | 230008172 | 1.52 | 83 | null | 2020-01-21 | 2020-01-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101500812 |
| 230001925 | 230008173 | 1.6 | 127 | null | null | 2020-02-13 | null | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100276572 |
| 230001926 | 230008174 | 1.74 | 91.55 | null | null | 2019-03-03 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101443646 |